US approves Gilead’s twice-yearly injection to prevent HIV 3 min read HEALTH US approves Gilead’s twice-yearly injection to prevent HIV IndiaNews12 June 19, 2025 Lenacapavir, marketed under the brand name Yeztugo, has been shown to reduce the risk of HIV transmission... Read More Read more about US approves Gilead’s twice-yearly injection to prevent HIV
